NEUROONE MEDICAL TECHNOLOGIES CORP
NASDAQ: NMTC (NeuroOne Medical Technologies C)
Last update: 2 days ago, 5:26PM0.712
0.04 (6.11%)
| Previous Close | 0.671 |
| Open | 0.700 |
| Volume | 210,777 |
| Avg. Volume (3M) | 344,638 |
| Market Cap | 35,599,660 |
| Price / Sales | 3.61 |
| Price / Book | 4.17 |
| 52 Weeks Range | |
| Earnings Date | 16 Dec 2025 |
| Profit Margin | -114.67% |
| Operating Margin (TTM) | -193.29% |
| Diluted EPS (TTM) | -0.230 |
| Quarterly Revenue Growth (YOY) | 0.70% |
| Total Debt/Equity (MRQ) | 27.66% |
| Current Ratio (MRQ) | 2.13 |
| Operating Cash Flow (TTM) | -4.88 M |
| Levered Free Cash Flow (TTM) | -2.66 M |
| Return on Assets (TTM) | -83.48% |
| Return on Equity (TTM) | -265.18% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | NeuroOne Medical Technologies C | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 3.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -4.0 |
| Average | -0.63 |
|
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 11.56% |
| % Held by Institutions | 10.96% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Sio Capital Management, Llc | 30 Sep 2025 | 2,360,635 |
| 52 Weeks Range | ||
| Median | 3.00 (321.35%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Maxim Group | 09 Sep 2025 | 3.00 (321.35%) | Buy | 0.894 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 19 Nov 2025 | Announcement | NeuroOne(R) Announces Upcoming Industry Conference Participation |
| 05 Nov 2025 | Announcement | NeuroOne(R) Receives 180-Day Extension From Nasdaq to Regain Minimum Bid Price Compliance |
| 16 Oct 2025 | Announcement | NeuroOne Promotes Emily Johns to Chief Administrative Officer |
| 14 Oct 2025 | Announcement | NeuroOne(R) Bolsters Patent Portfolio With Recent Decisions From Both the U.S. Patent & Trademark Office and European Patent Office |
| 06 Oct 2025 | Announcement | NeuroOne Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30 am EST |
| 29 Sep 2025 | Announcement | NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST |
| 16 Sep 2025 | Announcement | Sidoti Events, LLC's Virtual September Small-Cap Conference |
| 08 Sep 2025 | Announcement | NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |